Related references
Note: Only part of the references are listed.Influence of methotrexate and cisplatin on tumor progression and survival in the VM mouse model of systemic metastatic cancer
Leanne C. Huysentruyt et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The road to linearity: why linearity at low doses became the basis for carcinogen risk assessment
Edward J. Calabrese
ARCHIVES OF TOXICOLOGY (2009)
HIV-associated lymphomas and gamma-herpesviruses
Antonino Carbone et al.
BLOOD (2009)
Ultraviolet radiation and immunosuppression
G. M. Murphy
BRITISH JOURNAL OF DERMATOLOGY (2009)
Mammalian target of rapamycin inhibitors and their potential role in therapy in leukaemia and other haematological malignancies
David T. Teachey et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Targeting Mammalian Target of Rapamycin by Rapamycin Prevents Tumor Progression in an Oral-Specific Chemical Carcinogenesis Model
Rakefet Czeminski et al.
CANCER PREVENTION RESEARCH (2009)
Rapamycin Prevents Early Onset of Tumorigenesis in an Oral-Specific K-ras and p53 Two-Hit Carcinogenesis Model
Ana R. Raimondi et al.
CANCER RESEARCH (2009)
DNA repair-deficient Xpa/p53 knockout mice are sensitive to the non-genotoxic carcinogen cyclosporine A: escape of initiated cells from immunosurveillance?
Petra C. E. van Kesteren et al.
CARCINOGENESIS (2009)
Increased skin carcinogenesis in caspase-activated DNase knockout mice
Bin Yan et al.
CARCINOGENESIS (2009)
AKT/mTOR Pathway Activation and BCL-2 Family Proteins Modulate the Sensitivity of Human Small Cell Lung Cancer Cells to RAD001
Marin Marinov et al.
CLINICAL CANCER RESEARCH (2009)
Topical pimecrolimus and tacrolimus do not accelerate photocarcinogenesis in hairless mice after UVA or simulated solar radiation
Catharina M. Lerche et al.
EXPERIMENTAL DERMATOLOGY (2009)
Rapamycin Delays Tumor Development in Murine Livers by Inhibiting Proliferation of Hepatocytes with DNA Damage
Laura Elisa Buitrago-Molina et al.
HEPATOLOGY (2009)
Alternative Strategies for Toxicity Testing of Species-Specific Biopharmaceuticals
Jeanine L. Bussiere et al.
INTERNATIONAL JOURNAL OF TOXICOLOGY (2009)
JAK Pathway Induction of c-Myc Critical to IL-5 Stimulation of Cell Proliferation and Inhibition of Apoptosis
Wei-Hwa Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2009)
Radiation-Induced Mammary Carcinogenesis in Rodent Models: What's Different from Chemical Carcinogenesis?
Tatsuhiko Imaoka et al.
JOURNAL OF RADIATION RESEARCH (2009)
Squamous Cell Carcinomas in 2 Patients with Diffuse Scleroderma Treated with Mycophenolate Mofetil
Aliya Gulamhusein et al.
JOURNAL OF RHEUMATOLOGY (2009)
T-CELL LYMPHOPROLIFERATIVE DISORDER FOLLOWING MYCOPHENOLATE TREATMENT FOR MYASTHENIA GRAVIS
Dena B. Dubal et al.
MUSCLE & NERVE (2009)
Update on genotoxicity and carcinogenicity testing of 472 marketed pharmaceuticals
Giovanni Brambilla et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2009)
Mechanisms of non-genotoxic carcinogens and importance of a weight of evidence approach
Lya G. Hernandez et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2009)
Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis
Sunhwa Kim et al.
NATURE (2009)
Immunosuppressive therapy and post-transplant malignancy
Sophie Domhan et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Spontaneous remission of methotrexate-associated lymphoproliferative disorders after discontinuation of immunosuppressive treatment for autoimmune disease. Review of the literature
Rita Rizzi et al.
MEDICAL ONCOLOGY (2009)
Radiation Leukemogenesis in Mice: Loss of PU.1 on Chromosome 2 in CBA and C57BL/6 Mice after Irradiation with 1 GeV/nucleon 56Fe Ions, X Rays or γ Rays. Part II. Theoretical Considerations Based on Microdosimetry and the Initial Induction of Chromosome Aberrations
Yuanlin Peng et al.
RADIATION RESEARCH (2009)
Points to Consider on the Statistical Analysis of Rodent Cancer Bioassay Data When Incorporating Historical Control Data
Susan A. Elmore et al.
TOXICOLOGIC PATHOLOGY (2009)
Microenvironmental regulation of metastasis
Johanna A. Joyce et al.
NATURE REVIEWS CANCER (2009)
Topical thymidine dinucleotide treatment reduces development of ultraviolet-induced basal cell carcinoma in Ptch-1+/- mice
Simin Arad et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Malignancy after heart transplantation:: Incidence, prognosis and risk factors
M. G. Crespo-Leiro et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Skin cancer in organ transplant recipients -: Where do we stand today?
C. Ulrich et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Kaposi's sarcoma resolves after Sirolimus therapy in a patient with pemphigus vulgaris
Sarika Saggar et al.
ARCHIVES OF DERMATOLOGY (2008)
mTOR inhibitors are synergistic with methotrexate: an effective combination to treat acute lymphoblastic leukemia
David T. Teachey et al.
BLOOD (2008)
Atypical serum immunofixation patterns frequently emerge in immunomodulatory therapy and are associated with a high degree of response in multiple myeloma
Tomer Mark et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
Everolimus (RAD001) and anti-angiogenic cyclophosphamide show long-term control of gastric cancer growth in vivo
Daniel Cejka et al.
CANCER BIOLOGY & THERAPY (2008)
The growth-inhibitory effects of dexamethasone on renal cell carcinoma In Vivo and In Vitro
Yasuyuki Arai et al.
CANCER INVESTIGATION (2008)
Non-melanoma skin cancer: Importance of gender, immunosuppressive status and vitamin D
Tatiana M. Oberyszyn
CANCER LETTERS (2008)
Effects of oral administration of ciclosporin A on skin carcinogenesis: a study using the two-stage carcinogenesis protocol in mice
Y. Yajima et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2008)
Inhibition of Mammalian Target of Rapamycin by Rapamycin Causes the Regression of Carcinogen-induced Skin Tumor Lesions
Panomwat Amornphimoltham et al.
CLINICAL CANCER RESEARCH (2008)
PTEN loss does not predict for response to RAD001 (everolimus) in a glioblastoma orthotopic xenograft test panel
Lin Yang et al.
CLINICAL CANCER RESEARCH (2008)
The immune system - is it relevant to cancer development, progression and treatment?
R. J. Prestwich et al.
CLINICAL ONCOLOGY (2008)
Immune surveillance: a balance between protumor and antitumor immunity
Suzanne Ostrand-Rosenberg
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Evolving epidemiology of malignancies in HIV
Fabrice Bonnet et al.
CURRENT OPINION IN ONCOLOGY (2008)
Pivotal Role of mTOR Signaling in Hepatocellular Carcinoma
Augusto Villanueva et al.
GASTROENTEROLOGY (2008)
The flip side of immune surveillance: immune dependency
Richmond T. Prehn et al.
IMMUNOLOGICAL REVIEWS (2008)
Risk of Nonmelanoma Skin Cancer with Azathioprine Use
Jessica S. Maddox et al.
INFLAMMATORY BOWEL DISEASES (2008)
Identifying Optimal Biologic Doses of Everolimus (RAD001) in Patients With Cancer Based on the Modeling of Preclinical and Clinical Pharmacokinetic and Pharmacodynamic Data
Chiaki Tanaka et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Natural killer cells in innate immunity and cancer
Brian Becknell et al.
JOURNAL OF IMMUNOTHERAPY (2008)
Hazard identification and risk assessment for biologics targeting the immune system
Andrea B. Weir
JOURNAL OF IMMUNOTOXICOLOGY (2008)
Infectious aetiology of Hodgkin and non-Hodgkin lymphomas: a review of the epidemiological evidence
H. Hjalgrim et al.
JOURNAL OF INTERNAL MEDICINE (2008)
Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A
Brian C. Wulff et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2008)
Epstein Barr Virus-Associated Primary CNS Lymphomas in Elderly Patients on Immunosuppressive Medications
B. K. Kleinschmidt-DeMasters et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2008)
Failure of immunosuppressive drug levels to predict T-cell reactivity in pediatric transplant patients
Valerie B. Sampson et al.
JOURNAL OF PEDIATRIC SURGERY (2008)
Safety assessment of biopharmaceuticals: Japanese perspective on ICHS6 guideline maintenance
Takahiro Nakazawa et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2008)
Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors
Gunnar Johansson et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Malignancy after solid organ transplantation: An overview
S. Yousuf Zafar et al.
ONCOLOGIST (2008)
Chemical carcinogenesis studies in nonhuman primates
Shozo Takayama et al.
PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES (2008)
Intrinsic sensor of oncogenic transformation induces a signal for innate immunosurveillance
Arun M. Unni et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Differential Gene Signatures in Rat Mammary Tumors Induced by DMBA and Those Induced by Fractionated γ Radiation
Hae-June Lee et al.
RADIATION RESEARCH (2008)
Duration of chronic toxicity studies for biotechnology-derived pharmaceuticals: Is 6 months still appropriate?
Janet Clarke et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2008)
Kaposi sarcoma in transplantation
Céleste Lebbé et al.
Transplantation Reviews (2008)
Effect of Cyclosporin A and Tacrolimus on sister chromatid exchange frequency in renal transplant patients
Sukru Ozturk et al.
GENETIC TESTING (2008)
Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis
F. J. Duncan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2007)
Cancer after renal transplantation
Brahm Vasudev et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2007)
RAD inhibition of sarcoma growth: implications for laryngeal transplantation
Philip Daniel Knott et al.
AMERICAN JOURNAL OF OTOLARYNGOLOGY (2007)
Spontaneous neoplasms observed in cynomolgus monkeys (Macaca fascicularis) during a 15-year period
J. Kaspareit et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2007)
UV-induced immune suppression and photocarcino genesis: Chemoprevention by dietary botanical agents
Santosh K. Katiyar
CANCER LETTERS (2007)
The Hedgehog receptor Patched controls lymphoid lineage commitment
Anja Uhmann et al.
BLOOD (2007)
HIV-Associated Kaposi sarcoma and gender
Jayson Wang et al.
GENDER MEDICINE (2007)
RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model
Seiji Mabuchi et al.
CLINICAL CANCER RESEARCH (2007)
Antiproliferative and apoptotic effects of mycophenolic acid in human B-cell non-Hodgkin lymphomas
Gyula Vegso et al.
LEUKEMIA RESEARCH (2007)
Calcineurin inhibitors and rapamycin:: cancer protection or promotion?
Maren Weischer et al.
EXPERIMENTAL DERMATOLOGY (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Use of proliferation signal inhibitors in non-melanoma skin cancer following renal transplantation
J. W. de Fijter
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Kaposi's sarcoma in renal transplant recipients - the impact of proliferation signal inhibitors
Josep M. Campistol et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Direct visualization of macrophage-assisted tumor cell intravasation in mammary tumors
Jeffrey B. Wyckoff et al.
CANCER RESEARCH (2007)
RAD001 (everolimus) delays tumor onset and progression in a transgenic mouse model of ovarian cancer
Seiji Mabuchi et al.
CANCER RESEARCH (2007)
Mycophenolate mofetil inhibits tumor growth and angiogenesis in vitro but has variable antitumor effects in vivo, possibly related to bioavailability
G. E. Koehl et al.
TRANSPLANTATION (2007)
Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma
Rebecca C. Taylor et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Effect of iguratimod and other anti-rheumatic drugs on adenocarcinoma colon 26-induced cachexia in mice
K. Tanaka et al.
INFLAMMATION RESEARCH (2007)
Issues in the design and interpretation of chronic toxicity and carcinogenicity studies in rodents: Approaches to dose selection
Lorenz R. Rhomberg et al.
CRITICAL REVIEWS IN TOXICOLOGY (2007)
Maximizing mouse cancer models
Kristopher K. Frese et al.
NATURE REVIEWS CANCER (2007)
Epstein-Barr virus-associated lymphoproliferative disorders
Sherif A. Rezk et al.
HUMAN PATHOLOGY (2007)
Enhanced metastatic dissemination to multiple organs by melanoma and lymphoma cells in timp-3-/- mice
W. Cruz-Munoz et al.
ONCOGENE (2006)
Cytokines in breast cancer
A. Nicolini et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2006)
Development of de novo cancer in p53 knock-out mice is dependent on the type of long-term immunosuppression used
Gudrun E. Koehl et al.
TRANSPLANTATION (2006)
Radiation carcinogenesis in mouse thymic lymphomas
Ryo Kominami et al.
CANCER SCIENCE (2006)
Glucocorticoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells
Akihiro Yano et al.
CLINICAL CANCER RESEARCH (2006)
Everolimus (RAD) inhibits in vivo growth of murine squamous cell carcinoma (SCC VII)
SS Khariwala et al.
LARYNGOSCOPE (2006)
Chronic inflammation: A common and important factor in the pathogenesis of neoplasia
D Schottenfeld et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2006)
IL-18 reduces ultraviolet radiation-induced DNA damage and thereby affects photoimmunosuppression
Agatha Schwarz et al.
JOURNAL OF IMMUNOLOGY (2006)
Newer therapeutic approaches for systemic lupus erythematosus: Immunosuppressive agents
MA Dooley et al.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA (2006)
The carcinogenic potential of tacrolimus ointment beyond immune suppression:: a hypothesis creating case report
JC Becker et al.
BMC CANCER (2006)
Role of tumor-associated macrophages in tumor progression and invasion
Alberto Mantovani et al.
CANCER AND METASTASIS REVIEWS (2006)
Inhibition of tumor growth in immunocompromised hosts by restoring type-2 immunity using infusion of G-CSF-treated allogeneic CD8+ leukocytes
I Ohmori et al.
CYTOKINE (2005)
Reduction of primordial follicles caused by maternal treatment with busulfan promotes endometrial adenocarcinoma development in Donryu rats
M Yoshida et al.
JOURNAL OF REPRODUCTION AND DEVELOPMENT (2005)
Posttransplant lymphoproliferative disorders after renal transplantation in the United States in era of modern immunosuppression
S Caillard et al.
TRANSPLANTATION (2005)
Low-dose methotrexate inhibits lung metastasis and lengthens survival in rat osteosarcoma
R Tomoda et al.
CLINICAL & EXPERIMENTAL METASTASIS (2005)
Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck
P Amornphimoltham et al.
CANCER RESEARCH (2005)
Supplement to the Carcinogenic Potency Database (CPDB): Results of animal bioassays published in the general literature through 1997 and by the National Toxicology Program in 1997-1998
LS Gold et al.
TOXICOLOGICAL SCIENCES (2005)
Post-transplant lymphoproliferative disorders: molecular basis of disease histogenesis and pathogenesis
D Capello et al.
HEMATOLOGICAL ONCOLOGY (2005)
A genetically defined mouse ovarian carcinoma model for the molecular characterization of pathway-targeted therapy and tumor resistance
DY Xing et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Integrative radiation carcinogenesis: interactions between cell and tissue responses to DNA damage
MH Barcellos-Hoff
SEMINARS IN CANCER BIOLOGY (2005)
Anti-rejection drug treatment increases basal cell carcinoma burden in Ptch1+/- mice
A Vogt et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Plasma cell leukemia occurring in a patient with thrombocythemia treated with hydroxyurea and busulphan
A Candoni et al.
LEUKEMIA & LYMPHOMA (2004)
Toxic effects of ultraviolet radiation on the skin
Y Matsumura et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2004)
Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer
DJ Boffa et al.
CLINICAL CANCER RESEARCH (2004)
Cancer after kidney transplantation in the United States
BL Kasiske et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Rapamycin protects allografts from rejection while simultaneously attacking tumors in immunosuppressed mice
GE Koehl et al.
TRANSPLANTATION (2004)
Mycophenolate mofetil attenuates Walker's tumor growth when used alone, but the effect is lost when associated with cyclosporine
SL Silva et al.
TRANSPLANTATION PROCEEDINGS (2004)
Tacrolimus enhances transforming growth factor-β1 expression and promotes tumor progression
M Maluccio et al.
TRANSPLANTATION (2003)
Species comparison of anatomical and functional immune system development
MP Holsapple et al.
BIRTH DEFECTS RESEARCH PART B-DEVELOPMENTAL AND REPRODUCTIVE TOXICOLOGY (2003)
Implications of the lack of accuracy of the lifetime rodent bioassay for predicting human carcinogenicity
FK Ennever et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2003)
Species differences in the structure and function of the immune system
PJ Haley
TOXICOLOGY (2003)
Epstein-Barr virus (EBV)-positive lymphoproliferations in post-transplant patients show immunoglobulin V gene mutation patterns suggesting interference of EBV with normal B cell differentiation processes
A Bräuninger et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses
M Majewski et al.
TRANSPLANTATION (2003)
From clinical to human toxicology: linking animal research and risk assessment in man
J Descotes
TOXICOLOGY LETTERS (2003)
Tumorigenesis in high-dose total body irradiated rhesus monkeys - A life span study
CF Hollander et al.
TOXICOLOGIC PATHOLOGY (2003)
Do the immunosuppressive drugs used as treatment for graft-versus-host disease directly inhibit lymphoid tumor cell growth?
S D'Costa et al.
LEUKEMIA & LYMPHOMA (2003)
Topical application of the immunosuppressant tacrolimus accelerates carcinogenesis in mouse skin
Y Niwa et al.
BRITISH JOURNAL OF DERMATOLOGY (2003)
Chemokines: key players in cancer
M Arya et al.
CURRENT MEDICAL RESEARCH AND OPINION (2003)
Regulation of growth-related genes by interleukin-6 in murine myeloma cells
S Côté et al.
CYTOKINE (2002)
Cancer immunoediting: from immunosurveillance to tumor escape
GP Dunn et al.
NATURE IMMUNOLOGY (2002)
A two-way interaction between hepatocyte growth factor and interleukin-6 in tissue invasion of lung cancer cell line
Y To et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Ras family genes: An interesting link between cell cycle and cancer
M Macaluso et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2002)
Reduction of the angiogenesis score and tumor growth in subcutaneously implanted colon carcinoma in a mouse model
JW Mall et al.
CHIRURG (2002)
Rapamycin blocks tumor progression: Unlinking immunosuppression from antitumor efficacy
FL Luan et al.
TRANSPLANTATION (2002)
Posttransplant lymphoproliferative disorder associated with an Epstein-Barr-related virus in cynomolgus monkeys
J Schmidtko et al.
TRANSPLANTATION (2002)
Fatal donor-derived Epstein-Barr virus-associated post-transplant lymphoproliferative disorder following reduced intensity volunteer-unrelated bone marrow transplant for myelodysplastic syndrome
AYL Ho et al.
BONE MARROW TRANSPLANTATION (2002)
Posttransplant lymphoproliferative disorder associated with primate gamma-herpesvirus in cynomolgus monkeys used in pig-to-primate renal xenotransplantation and primate renal allotransplantation
EF McInnes et al.
TRANSPLANTATION (2002)
DNA repair-deficient Xpa and Xpa/p53+/-knock-out mice:: Nature of the models
H van Steeg et al.
TOXICOLOGIC PATHOLOGY (2001)
CB6F1-rasH2 mouse: Overview of available data
T Usui et al.
TOXICOLOGIC PATHOLOGY (2001)
The Tg.AC (v-Ha-ras) Transgenic mouse: Nature of the model
RW Tennant et al.
TOXICOLOGIC PATHOLOGY (2001)
The rasH2 transgenic mouse: Nature of the model and mechanistic studies on tumorigenesis
N Tamaoki
TOXICOLOGIC PATHOLOGY (2001)
p53+/- Hemizygous knockout mouse:: Overview of available data
RD Storer et al.
TOXICOLOGIC PATHOLOGY (2001)
Background and framework for ILSI's collaborative evaluation program on alternative models for carcinogenicity assessment
DE Robinson et al.
TOXICOLOGIC PATHOLOGY (2001)
Neonatal mouse model: Review of methods and results
RM McClain et al.
TOXICOLOGIC PATHOLOGY (2001)
In vivo inhibition of tumour growth by dexamethasone in murine osteosarcomas
I Kudawara et al.
EUROPEAN JOURNAL OF CANCER (2001)
The nature of the heterozygous Trp53 knockout model for identification of mutagenic carcinogens
J French et al.
TOXICOLOGIC PATHOLOGY (2001)
Tg.AC genetically altered mouse: Assay working group overview of available data
WC Eastin et al.
TOXICOLOGIC PATHOLOGY (2001)
Carcinogen-induced inflammation and immunosuppression are enhanced in xeroderma pigmentosum group A model mice associated with hyperproduction of prostaglandin E2
H Miyauchi-Hashimoto et al.
JOURNAL OF IMMUNOLOGY (2001)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Chemoprevention of vinyl carbamate-induced lung tumors in strain a mice
WT Gunning et al.
EXPERIMENTAL LUNG RESEARCH (2000)
Concordance of the toxicity of pharmaceuticals in humans and in animals
H Olson et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2000)
Interlaboratory comparison of the CB6F1-Tg rasH2 rapid carcinogenicity testing model
RR Maronpot et al.
TOXICOLOGY (2000)
The immunosuppressive macrolide RAD inhibits growth of human Epstein-Barr virus-transformed B lymphocytes in vitro and in vivo:: A potential approach to prevention and treatment of posttransplant lymphoproliferative disorders
M Majewski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
The carcinogenic risk of high dose total body irradiation in non-human primates
JJ Broerse et al.
RADIOTHERAPY AND ONCOLOGY (2000)
Assessment of immunosuppressant drug carcinogenicity: standard and alternative animal models
KL Hastings
HUMAN & EXPERIMENTAL TOXICOLOGY (2000)
Behavioral and immune changes in v-Ha-ras transgenic mice
LL Colombo et al.
IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY (2000)
Reversal of ultraviolet radiation-induced immune suppression by recombinant interleukin-12: suppression of cytokine production
DA Schmitt et al.
IMMUNOLOGY (2000)
Share Paper
